DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/22de3c/actavisdetailed_p) has announced the addition of the "Actavis-Detailed Product Pipeline" company profile to their offering.
Actavis-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
Scope of the reports:
Each Pipeline Report provides the user with real detail on a company's pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
Key Topics Covered:
- Business Summary
- Associated/Subsidiary Companies
- Product Glance
- - Products by Phase of Development
- - Products by Disease Hub Classification
- - Products by Indication
- Patent Expirations
- Upcoming Milestones
- Company Sales Figures
- - Product Revenue
- Product Summary
- Product Details
- Recent Updates
For more information visit http://www.researchandmarkets.com/research/22de3c/actavisdetailed_p
Source: Life Science Analytics